Recurrent astrocytoma in a child: A report of cytogenetics and TP53 gene mutation screening

被引:0
|
作者
Dam, A
Fock, JM
Hayes, VM
Molenaar, WM
van den Berg, E
机构
[1] Univ Groningen Hosp, Dept Pathol, NL-9713 GZ Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Child Neurol, NL-9713 GZ Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Med Genet, NL-9713 GZ Groningen, Netherlands
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An 8-year-old girl presented with a cerebral tumor and 3 recurrences within 15 months, The primary tumor was a low-grade astrocytoma, but the recurrences showed progressively malignant phenotypes with increasing mitotic activity and MIB-1 labeling indices. Radiotherapy was given between the first and the second recurrences. Cytogenetic analysis of the first and the second recurrences showed abnormal karyotypes. There seemed to be 2 common breakpoints in these 2 recurrences. TP53 gene mutation screening, using comprehensive denaturing gradient gel electrophoresis, revealed among others a possibly causative mutation of exon 5 in 3 of 4 tumor samples, The meaning of TP53 mutations in low-grade astrocytomas is still unclear, but the highly abnormal karyotypes, which are unusual in these tumors, probably provide genetic evidence for the unexpected aggressive behavior of the tumor in this patient.
引用
收藏
页码:184 / 189
页数:6
相关论文
共 50 条
  • [11] Mutation and function of TP53
    Milner, J
    BRAIN PATHOLOGY, 2000, 10 (04) : 504 - 504
  • [12] The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
    Leroy, Bernard
    Fournier, Jean Louis
    Ishioka, Chikashi
    Monti, Paola
    Inga, Alberto
    Fronza, Gilberto
    Soussi, Thierry
    NUCLEIC ACIDS RESEARCH, 2013, 41 (D1) : D962 - D969
  • [13] Specificity of TP53 mutation screening methods in cancerous tissues
    Breton, J
    Lechevrel, M
    Sichel, F
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (01) : 254 - 255
  • [14] TP53 mutation screening for patients at risk of myeloid malignancy
    Mukherjee, Devdeep
    Lawal, Rialnat A.
    Fitzhugh, Courtney D.
    Hourigan, Christopher S.
    Dillon, Laura W.
    LEUKEMIA, 2024, 38 (07) : 1604 - 1608
  • [15] A case report and literature review on TP53 gene mutation in a bladder rhabdomyosarcoma patient
    Li, Yixuan
    Yang, Tianci
    Zheng, Zhouhang
    Wang, Zhong
    Umar, Shahzard Muhammad
    Fan, Ning
    He, Shenbao
    Chang, Wei
    Wang, Wei
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [16] TP53 Action and the Consequences of TP53 Mutation in Acute Myeloid Leukemia
    Lowe, Scott W.
    BLOOD, 2019, 134
  • [17] Screening newborns for TP53
    Zlotogora, Joel
    LANCET ONCOLOGY, 2009, 10 (12): : 1142 - 1142
  • [18] Effect of hypoxia and TP53 mutation status and cytogenetics of normal and malignant mammary epithelium
    Vidarsson, H
    Steinarsdóttir, M
    Jónasson, JG
    Júlíusdóttir, K
    Ögmundsdóttir, HM
    CANCER GENETICS AND CYTOGENETICS, 2006, 165 (02) : 144 - 150
  • [19] Screening for TP53 rearrangements in families with the Li–Fraumeni syndrome reveals a complete deletion of the TP53 gene
    Gaëlle Bougeard
    Laurence Brugières
    Agnès Chompret
    Paul Gesta
    Françoise Charbonnier
    Alexander Valent
    Cosette Martin
    Grégory Raux
    Jean Feunteun
    Brigitte Bressac-de Paillerets
    Thierry Frébourg
    Oncogene, 2003, 22 : 840 - 846
  • [20] Recurrent TP53 missense mutation in cancer patients of Arab descent
    Zick, Aviad
    Kadouri, Luna
    Cohen, Sherri
    Frohlinger, Michael
    Hamburger, Tamar
    Zvi, Naama
    Plaser, Morasha
    Avital, Eilat
    Breuier, Shani
    Elian, Firase
    Salah, Azzam
    Goldberg, Yael
    Peretz, Tamar
    FAMILIAL CANCER, 2017, 16 (02) : 295 - 301